Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
22.79
-0.64 (-2.73%)
Aug 31, 2026, 12:42 PM EDT - Market open
Bicara Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst BMO Capital No rating | BMO Capital | Buy Initiates $35 | Buy | Initiates | $35 | +53.58% | Aug 18, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $45 | Buy | Maintains | $45 | +97.46% | Aug 14, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $33 | Buy | Maintains | $33 | +44.80% | Aug 13, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Maintains $20 | Hold | Maintains | $20 | -12.24% | Aug 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $39 → $37 | Buy | Maintains | $39 → $37 | +62.35% | Aug 12, 2026 |
| BTIG | BTIG | Buy Reiterates $28 → $39 | Buy | Reiterates | $28 → $39 | +71.13% | Aug 12, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Reiterates $18 → $20 | Hold | Reiterates | $18 → $20 | -12.24% | Aug 12, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $16 → $23 | Hold | Reiterates | $16 → $23 | +0.92% | Aug 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.